Extract
BioSante Announces CaP Manufacturing Agreement and Progress in Protein Delivery.
LINCOLNSHIRE, Ill. -- BioSante Pharmaceuticals, Inc. (AMEX:BPA) today announced a new manufacturing agreement with a U.S.-based cGMP (current good manufacturing practices) manufacturer for large-scale quantitie...
See the full content of this document
Sponsored links
